Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01790308
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT01790308
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT01790308. Randomized; no masking; primary purpose treatment. Start 2013-02 (registry gives no type); primary completion 2014-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- CSII
- Intervention (Drug)
- Liraglutide
- Lead sponsor
- Sun Yat-sen University
Record details
- Record id
cardio:ct-nct01790308- Content hash
91ea1a505bf701a809e48b7110683085818bf3636bc21357aa1d27fc806f77cf